1. Home
  2. MTB vs ONC Comparison

MTB vs ONC Comparison

Compare MTB & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo M&T Bank Corporation

MTB

M&T Bank Corporation

HOLD

Current Price

$240.12

Market Cap

35.0B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$308.59

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTB
ONC
Founded
1856
2010
Country
United States
Switzerland
Employees
21866
12000
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.0B
31.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MTB
ONC
Price
$240.12
$308.59
Analyst Decision
Hold
Strong Buy
Analyst Count
17
10
Target Price
$228.59
$385.10
AVG Volume (30 Days)
1.0M
311.4K
Earning Date
04-15-2026
05-06-2026
Dividend Yield
2.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.87
$723.76
Revenue Next Year
$3.66
$15.04
P/E Ratio
$13.63
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$174.76
$249.00
52 Week High
$243.57
$385.22

Technical Indicators

Market Signals
Indicator
MTB
ONC
Relative Strength Index (RSI) 67.40 66.33
Support Level $211.90 $305.56
Resistance Level N/A $310.50
Average True Range (ATR) 4.03 7.78
MACD 0.47 5.15
Stochastic Oscillator 82.33 84.20

Price Performance

Historical Comparison
MTB
ONC

About MTB M&T Bank Corporation

M&T Bank is a US regional bank with around $215 billion in assets as of the end of the first quarter of 2026. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: